title: Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Service d'Hématologie Clinique, Groupe Francophone des Myélodysplasies (GFM), Hôpital St Louis (Assistance Publique, Hôpitaux de Paris) and Paris 7 University, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
authors.affiliation: Clinics of Hematology and Medical Oncology, University Medicine, Goettingen, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Haase
authors.affiliation: Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
authors.forename: G F
authors.initials: GF
authors.lastname: Sanz
authors.affiliation: Functional Unit of Haematology, AOU Careggi, University of Florence, Firenze, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Santini
authors.affiliation: Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital, Ulm, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Buske
mesh_terms: D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006287:Health Planning Guidelines; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D012955:Societies, Medical / Q000592:standards*